Sweden's biotechnology R&D expenditure in 2026 was 550 M $, ranking 16 out of 197 countries. The zero figure does not reflect reality: Sweden has historically invested heavily in biotech through public funds and private companies. The Karolinska Institute in Stockholm, one of the world's leading medical universities, receives hundreds of millions of kronor annually for genomic research. However, in international databases these expenses are often classified under other categories (healthcare, university grants), leading to an understated value.
Sweden world ranking
Country position on the scale from last to first place for this indicator.
Change over time
Change in indicator over the available period.
Values — $
Top countries by Biotechnology R&D expenditure
Where Sweden stands in the world ranking.
People also search for
Other pages of the reference by this indicator.